Novavax (NVAX) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $7.90 -2.11%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $6.3 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- 374Water Inc (SCWO) Misses Q2 EPS by 15c
- Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
